11,998 views
A report by Petr Bulychkin, PhD, Senior Researcher, Department of Radiotherapy, Research Institute of Clinical and Experimental Radiology, N.N. Blokhin National Medical Research Center of Oncology, as part of the round table "Prostate Cancer: Medicine, Finance, Law". The round table was held by the Together Against Cancer Foundation on January 26, 2022. Timecodes 1:02 Comparison of 2D conventional, 3D conformal, and intensity modulated radiation therapy 3:00 Radiation therapy for localized cancer (ProtecT study) 4:09 Toxicity in IMRT 4:43 Effect of SOD on efficacy (MDACC study) 5:27 Place of 2D conventional radiation therapy in clinical guidelines 7:02 Radiation therapy for stage TxN1M0 8:50 Salvage and adjuvant radiation therapy 10:30 Symptomatic/palliative radiation therapy